© A. Herzog 2020 EPFL - The Werner Siemens Foundation has given a major grant to the Supramolecular Nano-Materials and Interfaces Laboratory (SuNMIL), headed by Francesco Stellacci, within EPFL's School of Engineering. His team, which is working on a compound that can block viral activity, hopes to make progress in the fight against SARS-CoV-2. "I was delighted when I found out about the grant," says Stellacci. "It's even better than I could've imagined. The Werner Siemens Foundation has shown itself to be very generous." With this grant, Stellacci and his research team can finance the next phase of their research on antiviral drugs. "Our aim is to find a single drug that can halt the activity of several different viruses," says Stellacci. "We've already developed a treatment that works in vitro to block HIV, HRSV [human respiratory syncytial virus] and the dengue, Zika and herpes viruses.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
Your Benefits
- Access to all content
- Receive newsmails for news and jobs
- Post ads
